Jacob Smith25 Mar 2026Biotech firm Abivax is planning to raise funds after releasing key trial data, signaling strong confidence in its pipeline. The company says it is not rushing into a sale, keeping options open amid growing investor interest. #Biotech #Abivax #Healthcare #Investing #Pharma8 likes7 comments#biotech#investing#abivax#healthcare#pharma
